glp 1 and heart failure Effects of Glucagon-Like Peptide Receptor Agonist Initiation in Patients With With Reduced Ejection Fraction Implantable Cardiac Devices It's important to study the

Phase I clinical trial results for Amgens experimental weight-loss drug, MariTide, indicate it may provide longer-lasting effects compared to existing glucagon-like peptide-1 (GLP-1) treatments such as Novo Nordisks Wegovy and EliLillys Zepbound.

Research suggests that foods, such as eggs, vegetables, and olive oil, may help increase GLP-1 levels

High-protein, low-carb meals designed to fight bloat, balance hormones, and support fat burning

The FDA flagged marketing claims suggesting that compounded GLP-1s shared the same safety and efficacy profiles as their branded counterparts, noting that such labeling can mislead consumers and violate the Food, Drug, and Cosmetic Act